HMCCP Fund 1 & HMCC HCAF - January 2024 Update
January 2024 was another strong month for HMC Capital Partners Fund 1, closing up 6.6%. Following a successful capital raising in December, the Fund took up its $76 million pro-rata share of the Sigma Healthcare equity raising at $0.70/share. With Sigma closing the month up 3% at $1.04/share, the acquisition of these additional shares in Sigma delivered an unrealised gain of $37 million for the Fund.
Since inception in August 2022, HMC Capital Partners Fund 1 (Trust A) has delivered an aggregate return of 35.7% (net of fees).
The Fund continues to be available for applications on a monthly basis in either of the wholesale or retail strategies. For more information, please contact firstname.lastname@example.org.
Where past performance has been given for any product, you should consider any future investment based on the information available in the relevant disclosure document and pay particular attention to the risks of investment. Past performance is not a reliable indicator of future performance. This general information does not take into account your investment objectives, financial situation or needs. Before acting on this information you should consider the appropriateness of the information for your particular investment objectives and financial situation and seek advice from a financial adviser. For more information, please refer to the Information Memorandum for HMC Capital Partners Fund 1 and the PDS, SPDS and TMD for HMC Capital High Conviction Alternatives Fund.